Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED

YILMAZ, SERKAN; Karakayali, Onur; Kale, Ebru; Akdogan, Ahmet

doi:10.1016/j.ajem.2017.08.053

Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED

Atıf İçin Kopyala

YILMAZ S. , Karakayali O., Kale E., Akdogan A.

AMERICAN JOURNAL OF EMERGENCY MEDICINE, cilt.36, ss.435-441, 2018 (SCI İndekslerine Giren Dergi)

Cilt numarası: 36 Konu: 3
Basım Tarihi: 2018
Doi Numarası: 10.1016/j.ajem.2017.08.053
Dergi Adı: AMERICAN JOURNAL OF EMERGENCY MEDICINE
Sayfa Sayıları: ss.435-441

Özet

Aim: This study aims to evaluate the serum S100B levels to predict neuronal damage and poor clinical outcomes associated with the use of synthetic cannabinoids.